In the News
|
Carver Biosciences Announces Appointment of Three Members to its Scientific Advisory Board - January 17th, 2023
|
Carver Biosciences Launches with Seed Financing to Advance CRISPR/Cas13-based Technologies - September 15th, 2022
|
Stepping on the Cas13: Carver Biosciences Uses CRISPR to Target RNA Viruses - April 20th, 2022
|
The Future of Gene Editing Takes a Toolbox that Extends Beyond Cas9 - April 7th, 2022